Tiaa, Fsb Edwards Lifesciences Corp Transaction History

Tiaa, Fsb

$27.6 Billion
Q2 2023

A detailed history of Tiaa, Fsb transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Tiaa, Fsb holds 9,915 shares of EW stock, worth $671,840. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,915

Previous 9,928 0.13%

Holding current value

$671,840

Previous $821,000 13.89%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$81.41 - $94.33 $1,058 - $1,226	-13 Reduced 0.13%	9,915 $935,000
Q1 2023 Apr 19, 2023	SELL	$74.26 - $84.51 $103,518 - $117,806	-1,394 Reduced 12.31%	9,928 $821,000
Q4 2022 Jan 12, 2023	SELL	$68.3 - $87.44 $5.99 Million - $7.67 Million	-87,668 Reduced 88.56%	11,322 $845,000
Q3 2022 Oct 11, 2022	SELL	$82.37 - $107.29 $715,712 - $932,242	-8,689 Reduced 8.07%	98,990 $8.18 Million
Q2 2022 Aug 09, 2022	BUY	$86.5 - $128.27 $594,601 - $881,727	6,874 Added 6.82%	107,679 $10.2 Million
Q1 2022 Apr 13, 2022	BUY	$101.96 - $128.34 $267,135 - $336,250	2,620 Added 2.67%	100,805 $11.9 Million
Q4 2021 Feb 01, 2022	SELL	$106.37 - $130.68 $79,883 - $98,140	-751 Reduced 0.76%	98,185 $12.7 Million
Q3 2021 Oct 14, 2021	SELL	$102.91 - $122.75 $890,891 - $1.06 Million	-8,657 Reduced 8.05%	98,936 $11.2 Million
Q2 2021 Jul 21, 2021	BUY	$83.84 - $104.76 $8 Million - $9.99 Million	95,389 Added 781.62%	107,593 $11.1 Million
Q1 2021 Apr 21, 2021	BUY	$78.68 - $90.67 $22,738 - $26,203	289 Added 2.43%	12,204 $1.02 Million
Q4 2020 Jan 21, 2021	BUY	$71.69 - $91.23 $854,186 - $1.09 Million	11,915 New	11,915 $1.09 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiaa, Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Tiaa, Fsb with notifications on news.

Account